THURSDAY, Nov. 16 (HealthDay News) -- An experimental drug prevented bone tumors in 50 percent of mice in a preclinical study, researchers report.The results suggest this treatment may be able to prevent or treat metastatic tumors in bone, say scientists at the University of Texas M.D. Anderson Cancer Center.
They determined the drug, known as VEGF121/rGel, stopped specialized cells within the bone from destroying material to make room for embedded prostate tumors. The drug may also inhibit the growth of blood vessels that feed bone tumors.
The findings appear in the current issue of Cancer Research.
Continue reading Drug Might Squeeze Out Bone Cancer.
